期刊文献+

血管再狭窄的治疗进展 被引量:1

下载PDF
导出
摘要 球囊扩张、支架植入、旁路手术等方法是目前治疗下肢动脉硬化闭塞症的主要手段,而术后血管再狭窄(restenosis,RS)是影响手术远期通畅率的主要原因。有文献记载,旁路RS其远期发生率可高达40%[1-2],球囊扩张对于狭窄性病变的3年通畅率为61%,闭塞性病变为48%[3];RS已成为一个世界性难题。因此。
作者 蒋杰 熊国祚
出处 《现代医药卫生》 2012年第17期2646-2647,共2页 Journal of Modern Medicine & Health
基金 湖南省教育厅基金资助项目(2009C845)
  • 相关文献

参考文献16

  • 1ID, Ho K,J, Come MS. :-isk factors for failure of lower-extremity rt -arization procedures:are they different for bypass and percuta-.neous procedures?[J]. Semin Vase Surg, 2008,21 (3) : 143-153.
  • 2Singh N, Sidawy AN, DeZee K J, et al. Factors associated with early fai- lure of infrainguinal lower extremity arterial bypass[J]. J Vasc Surg, 2008, 47(3 ) : 556-561.
  • 3Guo LP, Huang HC, Li JZ. Hypoxia induces the expression and secretion of connective tissue growth factor and fibronectin by cultured renal corti- cal mvofibroblastsfJ1. Beiiin- Da Xue Xue Bao,2007,39( 1 ) :67-71.
  • 4Braun-Dullaeus RC, Mann M J, Dzau VJ. Cell cycle progression : new ther- apeutic target for vascular proliferative disease [J]. Circulation, 1998,98 ( i ) : 82-89.
  • 5Lee SG, Lee CW, Cheong SS, et al. Immediate and long-term outcomes of rotational atherectomy versus balloon angioplasty alone for treatment of diffuse in-stent restenosis[J]. Am J Cardiol, 1998, 82(2) : 140-143.
  • 6Ribichini F,Tomai F,De Luca G,et al. A multicenter,randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions:cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES)-study design and rationale [J]. J Cardiovasc Med (Hagerstown), 2009,10 (2) : 192-199.
  • 7Ge J, Han -, Jiang H, et al. RACTS:a prospective randomized antiplate- let trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: - ng-term clinical and angiographic outcome[J]. J Cardiovasc Pharmaeol, 2005,46 (2) : 162-166.
  • 8Kaminnyi AI, Lankin VZ, Samko AN, et al. Low daily dose of antioxidant probucol decreases incidence and severity of restenosis after transluminal coronary balloon angioplasty[J]. Bull Exp Biol Med,2005,139(2) : 183-185.
  • 9Shammas NW. Restenosis after lower extremity interventio-s:current sta- tus and future directions[J]. J Endovasc T her, 2009,16 Suppl 1 : S 1170- 1182.
  • 10Degertekin M, Serruys PW, Foley DP, et al. Persistent inb i',ition of neoin- timal hyperplasia after sirolimus-eluting stent implantation :long-term (up to 2 years) clinical, angiographic ,and intravascular ultrasound follow-up[J]. Circulation, 2002,106(13) : 1610-1613.

二级参考文献10

  • 1Fitzgibbon GM, Kafka HP, Leach A J, et al. Coronary by- pass graft fate and patient outcome: angiographic follow - up of 5 065 grafts related to survival and reoperation in 1 388 patients during 25 yeats [ J ]. J Am Coil Cardiol, 1996, 28(3) : 616 -626.
  • 2Kim KB, Lim C, Lee C, et al. Off-pump coronary artery bypass may decrease the patency of saphenous vein grafts [J]. Ann Thorac Surg, 2001,72(3) : S1033 -S1037.
  • 3Zoldhelyi P, McNatt J, Shelat HS, et al. Thromboresistance of balloon - injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor [J]. Circulation, 2000, 101(3) : 289 -295.
  • 4George SJ, Channon KM, Baker AH. Gene therapy and coronary artery bypass grafting: current perspectives [ J ].Curr Opin Mol Ther, 2006, 10(2) : 288 -294.
  • 5Roque M, Reis ED, Fuster V, et al. Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty [ J ]. J Am Coil Cardiol, 2000, 36(7): 2303-2310.
  • 6Golino P, Cirillo P, Calabro P, et al. Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries[J]. J Am Coll Cardiol, 2001, 38(2) : 569 -576.
  • 7Dahm AE, Andersen TO, Rosendaal F, et al. A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI) [J]. J Thromb Haemost, 2005, 3(4): 651 - 658.
  • 8Golino P. The inhibitors of the tissue factor: factor Ⅶ pathway [ J ]. Thromb Res, 2002, 106 ( 3 ) : V257 - V265.
  • 9Golino P, Forte L, De Rosa S. Inhibition of the tissue factor coagulation pathway [ J ]. Curr Vasc Pharmacol, 2004, 2(4) : 319 -327.
  • 10朱洪生,梁宏立,黄忠耀,催思涛,张景迎,陈诗书.p53病毒增强型质粒-脂质复合物对移植静脉新内膜增生的影响[J].中华实验外科杂志,1999,16(6):533-534. 被引量:2

共引文献2

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部